Swiss industrial conglomerate Metall Zug posted a reduced net loss of 4.40 million Swiss francs for the first half of 2026, narrowing from a larger shortfall in the prior-year period. Net sales rose 5.5% to 95.60 million francs on an organic basis, though reported figures were constrained by currency headwinds from a weaker U.S. dollar.
The group’s trading operating result reached break-even, while earnings before interest and taxes remained negative at 3.70 million francs. Structural changes and reduced research and development spending enabled the medical devices unit to return to profitability, with sales supported by higher unit volumes in the core slit lamp business.
Metall Zug noted persistent external pressures, including competitive challenges and FX volatility, which limited visibility for the remainder of 2026. The company maintained confidence in the medium- and long-term outlook for its business segments despite the challenging near-term environment.
